1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with Leukemia, Basophilic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K; Karasawa, A; Masaki, S; Matsubara, M; Ohmori, K | 1 |
1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Leukemia, Basophilic, Acute
| Article | Year |
|---|---|
Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells.
Topics: Animals; Anti-Allergic Agents; Arachidonic Acid; Calcium; Cell Degranulation; Cyclic AMP; Dibenzoxepins; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Imidazoles; Interleukin-13; Interleukin-2; Interleukin-3; Interleukin-4; Interleukin-6; Leukemia, Basophilic, Acute; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Olopatadine Hydrochloride; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2004 |